ipratropium drug combination fenoterol

01/01/1986 - "Duovent appears to be an effective drug in the treatment of bronchial asthma in children, both clinically and functionally."
01/01/1995 - "[Role of Bronchodual in the long-term treatment of asthma in children]."
01/01/1986 - "Duovent activity was compared with placebo in a double-blind study carried out in 20 children, aged between 5 and 14 years, suffering from bronchial asthma. "
01/01/1985 - "[Berodual in the treatment of bronchial asthma]."
01/01/1983 - "Only on children with severe asthma bronchiale an exclusive treatment with Berodual seems to be of modest protective effect."

01/01/1986 - "Efficacy and compliance to prolonged Duovent treatment of bronchospasm. "
01/01/1986 - "In conclusion, Duovent is a rational and effective combination in the treatment of bronchospasm."
01/01/1986 - "Duovent compared to carbuterol in the treatment of bronchospasm."
01/01/1986 - "Protective effect of Duovent on bronchospasm induced by carbachol in comparison with each of its components."
03/15/1983 - "[Fenoterol, ipratropium bromide and their combination in the therapy of bronchospasm]."

01/01/1999 - "To study clinical efficiency of 12-month administration of berodual in chronic obstructive bronchitis (COB). "
01/01/2000 - "Berodual is effective as monotherapy of chronic obstructive bronchitis."
01/01/1999 - "[Experience in long-term use of berodual in the treatment of patients with chronic obstructive bronchitis]."
01/01/2000 - "[Use of nebulizer in berodual treatment of patients with chronic obstructive bronchitis in exacerbation]."
01/01/1999 - "[Nebuliser delivery of berodual in patients with bronchial asthma and chronic obstructive bronchitis]."

01/01/1984 - "Peak expiratory flow rates were increased to a statistically significant degree during the Duovent period and, during this period, there was a significant reduction in day-time cough, night-time wheeze and night wakings . "
01/01/2002 - "Berodual caused no side effects, salgim provoked short-term cough in 6(19.4%) patients. "
01/01/1986 - "Cough, day-time and nocturnal dyspnoea and the number of additional sprays required were better controlled with Duovent. "
01/01/1986 - "In the subjects treated with Duovent, there was a clear reduction in cough and dyspnea and a significant increase in PEF. "

02/01/2011 - "Our data suggest that nebulized Ipraterol offers a statistically significant improvement in pulmonary function without significant systemic absorption causing hypokalemia, with the improvement being comparable to that achieved with nebulized Berodual."
02/01/2011 - "We also found that there were no significant differences in the degree of improvement in FEV1 and hypokalemia following treatment with Ipraterol and Berodual. "